In addition, it has been shown that high expression of CPSF6 and MAML1 in HCC is associated with poor patient prognosis and they might serve as a potential prognostic marker to predict hepatocarcinogenesis (Wang et al., 2016; Tan et al., 2021). Here, CPSF6 is linked to hepatocellular carcinoma.